Implantation or Injectable Dosage Form New Animal Drugs; Melarsomine Dihydrochloride for Injection
other · US Department of Health and Human Services · Rule · Published 1995-09-25 · Effective 1995-09-25 · 60 FR 49339
Document
Document number
95-23603
Federal Register citation
60 FR 49339
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
US Department of Health and Human Services
Publication date
1995-09-25
Effective date
1995-09-25
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Rhone Merieux, Inc. The NADA provides for intramuscular use of injectable melarsomine dihydrochloride for the treatment of heartworm disease in dogs.